Arpitha Parthasarathy, Gao Chun Y, Tripathi Brajendra K, Saravanamuthu Senthil, Zelenka Peggy
National Eye Institute, NIH, Rockville, MD 20852, USA.
Mol Vis. 2013;19:319-32. Epub 2013 Feb 7.
Although cyclin-dependent kinase 5 (Cdk5) inhibits the formation of junctions containing N-cadherin, the effect of Cdk5 on junctions containing E-cadherin is less clear. The present study investigates the functional significance of Cdk5 in forming and maintaining cell-cell stability in corneal epithelial cells.
A Cdk5-deficient human corneal limbal epithelial cell line was generated by lentiviral transduction of small hairpin RNA specific for Cdk5 (shCdk5-HCLE cells). A blasticidin-inducible vector for expression of Cdk5-specific short hairpin RNA (ShCdk5) was generated by recombination and packaged into non-replicative lentiviral particles for transduction of human corneal limbal epithelial (HCLE) cells. Blasticidin-resistant cells were isolated for analysis. Cell aggregations were performed using HCLE, Cdk5 inhibitor olomoucine, ShCdk5, and MDA-MB 231 cells in the presence and absence of calcium, and particle size was measured using image analysis software. Relative protein concentrations were measured with immunoblotting and quantitative densitometry. Total internal reflection fluorescence (TIRF) microscopy was performed on cells transfected with green fluorescent protein (GFP)-E-cadherin or GFP-p120, and internalization of boundary-localized proteins was analyzed with particle tracking software. The stability of surface-exposed proteins was determined by measuring the recovery of biotin-labeled proteins with affinity chromatography. Rho and Rac activity was measured with affinity chromatography and immunoblotting.
Examining the effect of Cdk5 on E-cadherin containing epithelial cell-cell adhesions using a corneal epithelial cell line (HCLE), we found that Cdk5 and Cdk5 (pY15) coimmunoprecipitate with E-cadherin and Cdk5 (pY15) colocalizes with E-cadherin at cell-cell junctions. Inhibiting Cdk5 activity in HCLE or suppressing Cdk5 expression in a stable HCLE-derived cell line (ShHCLE) decreased calcium-dependent cell adhesion, promoted the cytoplasmic localization of E-cadherin, and accelerated the loss of surface-biotinylated E-cadherin. TIRF microscopy of GFP-E-cadherin in transfected HCLE cells showed an actively internalized sub-population of E-cadherin, which was not bound to p120 as it was trafficked away from the cell-cell boundary. This population increased in the absence of Cdk5 activity, suggesting that Cdk5 inhibition promotes dissociation of p120/E-cadherin junctional complexes. These effects of Cdk5 inhibition or suppression were accompanied by decreased Rac activity, increased Rho activity, and enhanced binding of E-cadherin to the Rac effector Ras GTPase-activating-like protein (IQGAP1). Cdk5 inhibition also reduced adhesion in a cadherin-deficient cell line (MDA-MB-231) expressing exogenous E-cadherin, although Cdk5 inhibition promoted adhesion when these cells were transfected with N-cadherin, as previous studies of Cdk5 and N-cadherin predicted. Moreover, Cdk5 inhibition induced N-cadherin expression and formation of N-cadherin/p120 complexes in HCLE cells.
These results indicate that loss of Cdk5 activity destabilizes junctional complexes containing E-cadherin, leading to internalization of E-cadherin and upregulation of N-cadherin. Thus, Cdk5 activity promotes stability of E-cadherin-based cell-cell junctions and inhibits the E-cadherin-to-N-cadherin switch typical of epithelial-mesenchymal transitions.
尽管细胞周期蛋白依赖性激酶5(Cdk5)抑制含N-钙黏蛋白的连接的形成,但Cdk5对含E-钙黏蛋白的连接的影响尚不清楚。本研究探讨Cdk5在角膜上皮细胞中形成和维持细胞间稳定性的功能意义。
通过慢病毒转导针对Cdk5的小发夹RNA(shCdk5-HCLE细胞)构建了Cdk5缺陷型人角膜缘上皮细胞系。通过重组构建了用于表达Cdk5特异性短发夹RNA(ShCdk5)的杀稻瘟菌素诱导型载体,并包装成非复制性慢病毒颗粒用于转导人角膜缘上皮(HCLE)细胞。分离出抗杀稻瘟菌素的细胞进行分析。在有钙和无钙条件下,使用HCLE、Cdk5抑制剂olomoucine、ShCdk5和MDA-MB 231细胞进行细胞聚集实验,并使用图像分析软件测量颗粒大小。用免疫印迹和定量光密度法测量相对蛋白浓度。对转染了绿色荧光蛋白(GFP)-E-钙黏蛋白或GFP-p120的细胞进行全内反射荧光(TIRF)显微镜检查,并用颗粒追踪软件分析边界定位蛋白的内化情况。通过亲和层析测量生物素标记蛋白的回收率来确定表面暴露蛋白的稳定性。用亲和层析和免疫印迹法测量Rho和Rac活性。
使用角膜上皮细胞系(HCLE)研究Cdk5对含E-钙黏蛋白的上皮细胞间黏附的影响,我们发现Cdk5和Cdk5(pY15)与E-钙黏蛋白共免疫沉淀,且Cdk5(pY15)在细胞间连接处与E-钙黏蛋白共定位。抑制HCLE中的Cdk5活性或在稳定的HCLE衍生细胞系(ShHCLE)中抑制Cdk5表达会降低钙依赖性细胞黏附,促进E-钙黏蛋白的细胞质定位,并加速表面生物素化E-钙黏蛋白的丢失。对转染了GFP-E-钙黏蛋白的HCLE细胞进行TIRF显微镜检查显示,E-钙黏蛋白有一个活跃内化的亚群,当它从细胞间边界被转运走时,它不与p120结合。在没有Cdk5活性的情况下,这个亚群增加,这表明抑制Cdk5会促进p120/E-钙黏蛋白连接复合物的解离。Cdk5抑制或抑制的这些作用伴随着Rac活性降低、Rho活性增加以及E-钙黏蛋白与Rac效应器Ras GTP酶激活样蛋白(IQGAP1)的结合增强。Cdk5抑制也降低了表达外源性E-钙黏蛋白的钙黏蛋白缺陷细胞系(MDA-MB-231)中的黏附,尽管如先前关于Cdk5和N-钙黏蛋白的研究所预测的,当这些细胞转染N-钙黏蛋白时,Cdk5抑制会促进黏附。此外,Cdk5抑制诱导HCLE细胞中N-钙黏蛋白的表达和N-钙黏蛋白/p120复合物的形成。
这些结果表明,Cdk5活性的丧失会破坏含E-钙黏蛋白的连接复合物稳定性,导致E-钙黏蛋白内化和N-钙黏蛋白上调。因此,Cdk5活性促进基于E-钙黏蛋白的细胞间连接的稳定性,并抑制上皮-间质转化典型的E-钙黏蛋白向N-钙黏蛋白的转变。